Consolidated Statements of Changes in Stockholders' Deficiency (Unaudited) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2020	Sep. 30, 2019
Series A Preferred Stock [Member]
Balance	$ 1	$ 1	$ 1	$ 1	$ 1	$ 1	$ 1	$ 1
Balance, shares	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000
Preferred stock issued on conversion of convertible notes payable
Preferred stock issued on conversion of convertible notes payable, shares
Elimination of derivative liability due to debt settlement
Beneficial conversion feature on convertible preferred stock
Deemed dividend on convertible preferred stock
Preferred stock issued as compensation for financing
Preferred stock issued as compensation for financing, shares
Series B preferred stock dividend
Beneficial conversion feature on convertible notes payable
Deemed distributions to CEO
Net profit loss
Balance	$ 1	$ 1	$ 1	$ 1	$ 1	$ 1	$ 1	$ 1
Balance, shares	1,000	1,000	1,000	1,000	1,000	1,000	1,000	1,000
Series B Preferred Stock [Member]
Balance	$ 125	$ 125	$ 96	$ 96	$ 96		$ 96
Balance, shares	125,001	125,001	96,429	96,429	96,429		96,429
Preferred stock issued on conversion of convertible notes payable						$ 96
Preferred stock issued on conversion of convertible notes payable, shares						96,429
Elimination of derivative liability due to debt settlement
Beneficial conversion feature on convertible preferred stock
Deemed dividend on convertible preferred stock
Preferred stock issued as compensation for financing			$ 29
Preferred stock issued as compensation for financing, shares			28,572
Series B preferred stock dividend
Beneficial conversion feature on convertible notes payable
Deemed distributions to CEO
Net profit loss
Balance	$ 125	$ 125	$ 125	$ 96	$ 96	$ 96	$ 125	$ 96
Balance, shares	125,001	125,001	125,001	96,429	96,429	96,429	125,001	96,429
Common Stock [Member]
Balance	$ 9,642	$ 9,642	$ 9,642	$ 9,642	$ 9,642	$ 9,642	$ 9,642	$ 9,642
Balance, shares	9,640,915	9,640,915	9,640,915	9,640,915	9,640,915	9,640,915	9,640,915	9,640,915
Preferred stock issued on conversion of convertible notes payable
Preferred stock issued on conversion of convertible notes payable, shares
Elimination of derivative liability due to debt settlement
Beneficial conversion feature on convertible preferred stock
Deemed dividend on convertible preferred stock
Preferred stock issued as compensation for financing
Series B preferred stock dividend
Beneficial conversion feature on convertible notes payable
Deemed distributions to CEO
Net profit loss
Balance	$ 9,642	$ 9,642	$ 9,642	$ 9,642	$ 9,642	$ 9,642	$ 9,642	$ 9,642
Balance, shares	9,640,915	9,640,915	9,640,915	9,640,915	9,640,915	9,640,915	9,640,915	9,640,915
Additional Paid-In Capital [Member]
Balance	$ 7,102,316	$ 7,120,235	$ 6,885,944	$ 6,925,335	$ 6,925,335	$ 4,066,644	$ 6,885,944	$ 4,066,644
Preferred stock issued on conversion of convertible notes payable						2,397,152
Elimination of derivative liability due to debt settlement						461,539
Beneficial conversion feature on convertible preferred stock						2,397,248
Deemed dividend on convertible preferred stock						(2,397,248)
Preferred stock issued as compensation for financing			399,971
Series B preferred stock dividend	(9,986)	(9,987)	(9,986)
Beneficial conversion feature on convertible notes payable	108,750
Deemed distributions to CEO		(7,932)	(155,694)
Net profit loss
Balance	7,201,080	7,102,316	7,120,235	6,925,335	6,925,335	6,925,335	7,201,080	6,925,335
Accumulated Deficit [Member]
Balance	(8,727,153)	(8,917,391)	(6,905,767)	(7,836,496)	(7,335,533)	(7,128,606)	(6,905,767)	(7,128,606)
Preferred stock issued on conversion of convertible notes payable
Elimination of derivative liability due to debt settlement
Beneficial conversion feature on convertible preferred stock
Deemed dividend on convertible preferred stock
Preferred stock issued as compensation for financing
Series B preferred stock dividend
Beneficial conversion feature on convertible notes payable
Deemed distributions to CEO
Net profit loss	(1,059,657)	190,238	(2,011,624)	452,926	(500,963)	(206,927)
Balance	(9,786,810)	(8,727,153)	(8,917,391)	(7,383,570)	(7,836,496)	(7,335,533)	(9,786,810)	(7,383,570)
Balance	(1,615,069)	(1,787,388)	(10,084)	(901,422)	(400,459)	(3,052,319)	$ (10,084)	(3,052,319)
Preferred stock issued on conversion of convertible notes payable						2,397,248
Preferred stock issued on conversion of convertible notes payable, shares
Elimination of derivative liability due to debt settlement						461,539
Beneficial conversion feature on convertible preferred stock						2,397,248
Deemed dividend on convertible preferred stock						(2,397,248)
Preferred stock issued as compensation for financing			400,000
Series B preferred stock dividend	(9,986)	(9,987)	(9,986)
Beneficial conversion feature on convertible notes payable	108,750
Deemed distributions to CEO		(7,932)	(155,694)
Net profit loss	(1,059,657)	190,238	(2,011,624)	452,926	(500,963)	(206,927)	$ (2,881,043)	(254,964)
Balance	$ (2,575,962)	$ (1,615,069)	$ (1,787,388)	$ (448,496)	$ (901,422)	$ (400,459)	$ (2,575,962)	$ (448,496)

BRIDGEWAY NATIONAL CORP. 10-Q